Integrating Systematic Reviews into Supportive Care Trial Design: The Rethinking Clinical Trials (REaCT) Program

Purpose: To review the successes and challenges of integrating systematic reviews (SRs) into the Rethinking Clinical Trials (REaCT) Program. Methods: All REaCT program SRs were evaluated and descriptive summaries presented. Results: Twenty-two SRs have been performed evaluating standard of care inte...

Full description

Bibliographic Details
Main Authors: Bader Alshamsan, Brian Hutton, Michelle Liu, Lisa Vandermeer, Mark Clemons
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Current Oncology
Subjects:
Online Access:https://www.mdpi.com/1718-7729/29/12/750
Description
Summary:Purpose: To review the successes and challenges of integrating systematic reviews (SRs) into the Rethinking Clinical Trials (REaCT) Program. Methods: All REaCT program SRs were evaluated and descriptive summaries presented. Results: Twenty-two SRs have been performed evaluating standard of care interventions for the management of: breast cancer (<i>n</i> = 15), all tumour sites (<i>n</i> = 4), breast and prostate cancers (<i>n</i> = 2), and prostate cancer (<i>n</i> = 1). The majority of SRs were related to supportive care (<i>n</i> = 14) and survivorship (<i>n</i> = 5) interventions and most (19/22, 86%) confirmed the existence of uncertainty relating to the clinical question addressed in the SR. Most SRs (15/22, 68%) provided specific recommendations for future studies and results were incorporated into peer-reviewed grant applications (<i>n</i> = 6) and clinical trial design (<i>n</i> = 12). In 12/22 of the SRs, the first author was a trainee. All SRs followed PRISMA guidelines. Conclusion: SRs are important for identifying and confirming clinical equipoise and designing trials. SRs provide an excellent opportunity for trainees to participate in research.
ISSN:1198-0052
1718-7729